Understanding barriers to malaria control in the Asia-Pacific
Official title: Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region
Funded at Walter and Eliza Hall Inst Medical Res · NIH-11516992 · Data updated 2026-11-12
A research effort in Asia-Pacific countries aims to identify and overcome obstacles to eliminating malaria, focusing on Plasmodium falciparum and vivax in Cambodia and Papua New Guinea.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Walter and Eliza Hall Inst Medical Res NIH-funded |
| Lab location | 1 site (Parkville, AUSTRALIA) |
| Project start | April 1, 2025 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $42,210 |
| NIH project number | 3U19AI129392-11S3 |
| Project ID | NIH-11516992 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are residents in malaria-endemic regions in Cambodia and PNG, including people living in areas with residual vivax transmission.
✕Less likely to help
Individuals in non-endemic regions or those not exposed to the study interventions may not benefit.
What this research studies
This project brings together fieldwork, lab work, and modeling across five sites with varying malaria transmission. We will strengthen surveillance by combining traditional monitoring with targeted population surveys to find where transmission persists. We’ll study what drives ongoing vivax transmission and test locally tailored intervention packages to limit and interrupt malaria spread. The work will generate practical evidence on new tools and strategies to improve access to prevention and treatment in real-world settings.
Why it matters
Potential benefit: If successful, the project could lead to more effective, locally adapted malaria control efforts and help move communities toward elimination.
How similar studies have gone: Previous regional studies showed divergent malaria trends; this project builds on those findings using coordinated field, lab, and modeling approaches.
Where this research is happening
-
Walter and Eliza Hall Inst Medical Res
Parkville, Australia Active
Researchers
- Principal investigator: Mueller, Ivo J — Walter and Eliza Hall Inst Medical Res
- Study coordinator: Mueller, Ivo J
Related research
Other NIH-funded projects on the same topics.
-
Digital malaria surveillance in Ethiopia to improve outbreak detection
A collaboration to add a malaria-specific digital module to an existing surveillance system in Africa to help detect and respond to outbreaks faster.
-
Cross-sector partnership uses digital malaria surveillance in Ethiopia
A US-based team will adapt and test a digital malaria surveillance module in SORMAS to help detect and respond to malaria outbreaks in Ethiopia.
-
Malaria control project in Western Kenya to reduce illness and deaths
A large, multi-year effort in western Kenya will help track malaria spread and test ways to prevent transmission so fewer people get sick or die.
-
Optimizing tafenoquine dose to prevent relapse of vivax malaria in Asia
A study tests the best tafenoquine dose to prevent P. vivax malaria relapse in people in East Asia and Oceania.
-
Optimizing tafenoquine dose to prevent P. vivax malaria relapses in Asia
A study to find the best single-dose tafenoquine amount to prevent relapse of P. vivax malaria in people in East Asia and Oceania.
-
Severe malaria and brain risk in children
This grant studies how severe malaria in young children can affect brain development and long-term thinking and behavior, with a focus on kids in Uganda.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.